相关实验视频

Updated: Jun 25, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

KCNQ2突变导致独特的新生儿行为停止,没有运动发作:功能性特征

Swee-Hee Wong¹, Ying-Ming Liou², Jiann-Jou Yang³

¹Division of Pediatric Neurology, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Epilepsy & behavior : E&B

|May 24, 2024

概括

一个KCNQ2基因突变导致新生儿独特的新生儿发作. 功能性研究揭示了一种补偿机制,表明这种罕见的潜在治疗途径.

科学领域:

遗传学遗传学是一个
神经科学是一个神经科学.
分子生物学分子生物学

背景情况:

KCNQ2基因突变是新生儿发作的常见原因,经常导致严重的发育性脑病变 (DEE).
无意义的KCNQ2突变会导致一种独特的,自我限制的家族新生儿 (SLFNE),其潜在机制尚不清楚.

研究的目的:

研究与SLFNE相关的特定KCNQ2无意义突变 (p.Arg448Ter) 的临床表现和潜在机制.
探索p.Arg448Ter突变对KCNQ2通道功能和潜在补偿机制的功能影响.

主要方法:

对具有KCNQ2 c.1342C>T (p.Arg448Ter) 突变的试验对象和家庭成员的临床表型,脑电图 (EEG) 和神经发育结果评估.
试验室功能性研究涉及野生型和突变KCNQ2变异体转移到HEK293细胞中,以评估道功能,表达和对Retigabine的反应.

主要成果:

试验对象出现了独特的非运动性新生儿 (行为停止,自主性变化),在三个月大时缓解,在三岁时神经发育结果正常.
在体外,同质的p.Arg448Ter通道是非功能性的,但与野生类型KCNQ2或KCNQ2/KCNQ3的异质共同表达恢复了通道功能和表面表达.
雷提加部分挽救了含有p.Arg448Ter的异构体通道的功能,但没有影响同构体突变通道.

结论:

该p.Arg448Ter KCNQ2突变导致一个独特的新生儿发作表型,以非运动性发作为特征,与典型的KCNQ2相关DEE不同.
尽管是一种无意义的突变,但与野生类型KCNQ2和KCNQ3亚单元的异构相互作用提供了一个重要的补偿机制,解释了的自我限制性质.

关键词:

行为逮捕行为逮捕功能性研究是一项功能性研究.KCNQ2 的时间.新生儿发作新生儿发作现象型现象型是一种表现型.

更多相关视频

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

相关概念视频

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...